We are live on
!
Find out more
JC
JBF Capital Portfolio holdings
AUM
$764M
Turnover
38.35%
1-Year Est. Return
24.26%
This Fund
S&P 500
This Quarter
Est. Return
+4.93%
1 Year Est. Return
+24.26%
3 Year Est. Return
+93.63%
5 Year Est. Return
+127.41%
10 Year Est. Return
+469.69%
AUM
$679M
AUM Growth
+$26.4M
(+4.1%)
Cap. Flow
-$3.91M
Cap. Flow
% of AUM
-0.58%
Top 10 Holdings %
Top 10 Hldgs %
90.88%
Holding
113
New
14
Increased
7
Reduced
10
Closed
23
Avg Time Held
0.6
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$5.11M |
| 2 |
CELG
Celgene Corp
CELG
|
+$4.56M |
| 3 |
AbbVie
ABBV
|
+$3.18M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$3.14M |
| 5 |
Viatris
VTRS
|
+$2.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$4.08M |
| 2 |
Voya Financial
VOYA
|
+$2.87M |
| 3 |
United Parcel Service
UPS
|
+$2.82M |
| 4 |
Bank of America
BAC
|
+$2.33M |
| 5 |
JPMorgan Chase
JPM
|
+$2.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 86% |
| 2 | Financials | 4.81% |
| 3 | Healthcare | 4.69% |
| 4 | Materials | 0.93% |
| 5 | Technology | 0.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
LKQ Corp
LKQ
$5.66B
| – | – |
-20,000
| Closed | -$527K | – |
|
102
Malibu Boats
MBUU
$446M
| – | – |
-1,000
| Closed | -$22K | – |
|
103
The Bancorp
TBBK
$2B
| – | – |
-99,083
| Closed | -$1.86M | – |
|
104
Trueblue
TBI
$260M
| – | – |
-19,838
| Closed | -$580K | – |
|
105
TG Therapeutics
TGTX
$8.57B
| – | – |
-16,676
| Closed | -$115K | – |
|
|
106
Voya Financial
VOYA
$8.62B
| – | – |
-79,000
| Closed | -$2.87M | – |
|
|
ICPT
107
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| – | – |
-100
| Closed | -$33K | – |
|
|
CNCE
108
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| – | – |
-41,556
| Closed | -$559K | – |
|
|
HSTO
109
DELISTED
Histogen Inc. Common Stock
HSTO
| – | – |
-741
| Closed | -$1.21M | – |
|
|
CBST
110
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| – | – |
-5,100
| Closed | -$373K | – |
|
|
QCOR
111
DELISTED
QUESTCOR PHARMA INC
QCOR
| – | – |
-9,900
| Closed | -$643K | – |
|
|
BODY
112
DELISTED
BODY CENTRAL CORP COM STK
BODY
| – | – |
-1,000
| Closed | -$1K | – |
|
|
MDVN
113
DELISTED
MEDIVATION, INC.
MDVN
| – | – |
-70,000
| Closed | -$2.25M | – |
|
Similar funds
UCMOK
EIM
CAAM
KLI
CT
ANRF
NI
HI
JBF Capital's Q2 2014 Portfolio in Review
As of Q2 2014, JBF Capital held 113 positions worth $679M, up 4.1% from $652M the previous quarter. Its ten largest holdings account for 91% of the portfolio.
JBF Capital's Q2 2014 filing shows 14 new, 7 increased, 10 reduced and 23 closed positions. Its largest new stake was Teva Pharmaceutical Industries Limited: 100,000 shares worth $5.24M. The largest sale was Applied Materials, an estimated $4.08M.
By sector, the portfolio is most concentrated in Miscellaneous at 86% of assets, up from 86% a quarter earlier, followed by Financials and Healthcare.
- JBF Capital's largest Q2 2014 buy was Teva Pharmaceutical Industries Limited: 100,000 shares worth $5.24M.
- JBF Capital added most to Yahoo Inc in Q2 2014, an estimated $3.14M increase.
- JBF Capital's biggest Q2 2014 reduction was United Parcel Service, cutting an estimated $2.82M.
- JBF Capital fully exited Applied Materials in Q2 2014, selling an estimated $4.08M.
- JBF Capital's ten largest holdings make up 91% of its $679M portfolio in Q2 2014.
- JBF Capital opened 14 new positions and closed 23 in Q2 2014.
- JBF Capital's portfolio value rose 4.1% quarter-over-quarter to $679M.
Based on JBF Capital's 13F filing for Q2 2014, filed 13 Aug 2014.